Results 141 to 150 of about 2,796,329 (209)

Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications. [PDF]

AAPS J, 2014
Wang J, Wang YM, Ahn HY.
europepmc   +1 more source

Role of endogenous microbiota, probiotics and their biological products in human health. [PDF]

Nutrients, 2013
Howarth GS, Wang H.
europepmc   +1 more source

Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products [Corrigendum]. [PDF]

Patient Prefer Adherence, 2019
europepmc   +1 more source

Seafood Abundance Correlates With Nitrogen Stable Isotope Ratio in Japanese Diet. [PDF]

Rapid Commun Mass Spectrom
Yoshinaga J, Oyama R.
europepmc   +1 more source

Clarifying the critical differences between the enzymatic stromal vascular fraction and the mechanically derived stromal vascular tissue or nanofat for spinal cord injury applications. [PDF]

Stem Cell Res Ther
Nonnarath C, Serratrice N.
europepmc   +1 more source

Analysis of intellectual property strategies across different categories of digital therapeutics. [PDF]

Front Digit Health
Maeda T, Suzuki H, Saotome C.
europepmc   +1 more source

Artificial intelligence-based screening of phytochemicals for targeted cancer therapy. [PDF]

Nat Prod Bioprospect
Santiago LR, Asevedo EA, de Oliveira MEJ, Pereira KC, da Silva Trindade MF, Oliveira AGS, Rocha MA, Kang S, Rani A, Park MN, Tan MW, Tan MW, Syahputra RA, Kim B, de Azambuja Ribeiro RIM.   +14 more
europepmc   +1 more source

Non-signaling protein therapeutics: a mechanism-based regulatory framework to modernize biosimilar development and global harmonization. [PDF]

Front Med (Lausanne)
Niazi SK.
europepmc   +1 more source

Accessibility of Biologic Drugs in Morocco: Comparison with FDA and EMA Approvals (2015-2025). [PDF]

J Mark Access Health Policy
Charrak M, Cherrah Y, Serragui S.
europepmc   +1 more source